Thomas Kohl is a pediatrician with 20 years of clinical experience in minimally invasive fetal surgery. He developed, co-developed, and clinically introduced a large spectrum of fetal interventions. He pioneered the technique of fetoscopic closure of spina bifida, as well as the technique of fully percutaneous partial amniotic carbon dioxide insufflation (PACI). He co-developed fetoscopic tracheal balloon occlusion for the treatment of severe pulmonary hypoplasia from diaphragmatic hernia, anhydramnios, hydrothorax, and CPAM. He performed the first successful fetoscopic procedures in fetuses with laryngeal atresia and introduced the techniques of fetal intra-amniotic ultrasound, fetal transesophageal echocardiography and fetal transesophageal electrocardiography. Kohl furthermore developed new minimally invasive techniques for early second trimester shunt insertion in fetuses with LUTO and for fetuses with hydrothorax. He considers the treatment of hypoplastic cardiovascular structures in human fetuses by chronic intermittent materno–fetal hyperoxygenation his most important contribution. He is the founder of the German Center for Fetal Surgery & Minimally-Invasive Therapy (DZFT).
Thomas Kohl is a pediatrician with 20 years of clinical experience in minimally invasive fetal surgery. He developed, co-developed, and clinically introduced a large spectrum of fetal interventions. He pioneered the technique of fetoscopic closure of spina bifida, as well as the technique of fully percutaneous partial amniotic carbon dioxide insufflation (PACI). He co-developed fetoscopic tracheal balloon occlusion for the treatment of severe pulmonary hypoplasia from diaphragmatic hernia, anhydramnios, hydrothorax, and CPAM. He performed the first successful fetoscopic procedures in fetuses with laryngeal atresia and introduced the techniques of fetal intra-amniotic ultrasound, fetal transesophageal echocardiography and fetal transesophageal electrocardiography. Kohl furthermore developed new minimally invasive techniques for early second trimester shunt insertion in fetuses with LUTO and for fetuses with hydrothorax. He considers the treatment of hypoplastic cardiovascular structures in human fetuses by chronic intermittent materno–fetal hyperoxygenation his most important contribution. He is the founder of the German Center for Fetal Surgery & Minimally-Invasive Therapy (DZFT).